This peer-reviewed oral pathology article summarizes clinical evidence from Oral oncology (2026). It focuses on findings that may help dental professionals evaluate treatment decisions, patient outcomes, or clinical protocols.
Abstract
This review aims to evaluate the efficacy of vitamin E in the treatment of oral mucositis (OM). This review was conducted in accordance with Reporting Items for Systematic Reviews and Meta-analyses and registered in the International Prospective Register of Systematic Reviews (PROSPERO). The search was conducted in seven databases and in the Brazilian repository of Theses and Dissertations of CAPES, consulted as a complementary source identifying clinical trials that evaluated the use of vitamin E alone in cancer patients for the treatment of OM. The risk of bias was assessed using the Joanna Briggs Institute tool. The data were extracted and systematized in a meta-analysis using a fixed-effect model in RStudio software. Fourteen articles were included, which evaluated 715 patients, with 330 patients in the intervention group and 385 in the control group. Among the included studies, 64.3% (n = 9) showed a significant reduction in the incidence of severe OM with the use of vitamin E (p < 0.05). The risk of bias assessment indicated low methodological risk, with 65% (n = 9) classified as low overall risk. The meta-analysis showed a lower incidence of severe mucositis (grades 3-4) in the vitamin E group compared to controls (RR: 0.37; 95% CI: 0.25-0.57), with a consistent effect in pediatric (RR: 0.14; 95% CI: 0.05-0.35) and non-pediatric (RR: 0.57; 95% CI: 0.35-0.92) populations. The results suggest a potential benefit of vitamin E in the management of OM induced by antineoplastic therapies, especially in reducing the incidence of more severe forms of this condition.
Key takeaway
Key takeaway: This review-level evidence helps clinicians interpret the consistency and strength of available clinical findings in this topic area.
Peer-reviewed source
Deysimara de Cássia Santos, Larissa Torres Fernandes, Danielle Negri Ferreira Neves, Sibele Nascimento de Aquino, Gisele Queiroz Carvalho
Oral oncology. 2026
DOI: 10.1016/j.oraloncology.2026.107945
PMID: 41886966
PubMed: https://pubmed.ncbi.nlm.nih.gov/41886966/
Image: Evgeniy Kozlov (Unsplash)
Oral pathology 25 March 2026
Five years of experience teaching pathology to dental students using the WebMicroscope
There is an increasing tendency at medical universities to digitize whole microscope histopathological slides from teaching collections for web-based studies
Oral pathology 25 November 2025
Virtual microscopy (VM) is a technology for showing microscope slides using computers and could be considered a progression of classic methodology using optical microscopes.
Oral pathology 10 November 2025
Evolution of dental informatics as a major research tool in oral pathology
Bioinformatics is a relatively new field of science that incorporates the principles of biology and computer science.
Oral pathology 04 September 2025
The classic dental diseases, caries and periodontal disease, are commonly thought to have little effect on systemic health.
Let’s start with a question that tends to make people shift in their seats a little: Would you drink from your dental unit waterline?
News 11 May 2026
Food and Drug Administration (FDA) has granted FDA clearance for its Dx Software following a review completed on April 10, 2026.
The Dental Trade Alliance (DTA) Foundation announced the launch of the Gary & Deborah Steinberg Dental Assistant Scholarship , a new initiative designed to support dental assistant
Editorials 11 May 2026
Gwendelyn Tran, a second-year dental student at Texas A&M College of Dentistry, was among 37 recipients of travel grants from The American Association for Dental, Oral, and Craniof
The Sino-Dental 2026 will take place from June 9, 2026 to June 12, 2026 in Beijing, China, offering dental professionals a focused environment for continuing education, clinical updates and industry...